CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma

Abstract This study aims to discover the therapeutic effect of chemokine (CXC motif) receptor 4 (CXCR4) antagonist AMD3100 combined with transcatheter arterial chemoembolization (TACE) in a rat model with hepatocellular carcinoma (HCC). An orthotopic model of HCC was established and treated with T...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Hong‐Wei Lei, Bi‐Run Huang, Jie Cai, Cheng‐Ming Li, Chun‐Bo Shang, Zhi‐Yang Liao, Zheng‐Dong Wan
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2022-08-01
Ráidu:	Kaohsiung Journal of Medical Sciences
Fáttát:	AMD3100 CXCR4 hepatocellular carcinoma transcatheter arterial chemoembolization
Liŋkkat:	https://doi.org/10.1002/kjm2.12540
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!